Microbiology and Biotechnology Letters (한국미생물·생명공학회지)

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Genotyping and Molecular Characterization of Carbapenem-resistant Acinetobacter baumannii Strains Isolated from Intensive Care Unit Patients

  • Abozahra, Rania (Department of Microbiology and Immunology, Faculty of Pharmacy, Damanhour University) ;
  • Abdelhamid, Sarah M. (Department of Microbiology and Immunology, Faculty of Pharmacy, Damanhour University) ;
  • Elsheredy, Amel G. (Department of Microbiology, Medical Research Institute, Alexandria University) ;
  • Abdulwahab, Kawther E. (Department of Microbiology and Immunology, Faculty of Pharmacy, Damanhour University) ;
  • Baraka, Kholoud (Department of Microbiology and Immunology, Faculty of Pharmacy, Damanhour University)
  • Received : 2020.08.20
  • Accepted : 2021.03.16
  • Published : 2021.06.28
Download PDF
⟨ Previous Next ⟩

Abstract

The emergence of multidrug-resistant Acinetobacter baumannii has partly increased treatment failure and patient mortality. Class D β-lactamases is an important mechanism of resistance to beta-lactam antibiotics in this species. This study aimed to investigate the relationship between the presence oxacillinase gene and genetic fingerprints of A. baumannii isolates from the intensive care unit of an Egyptian tertiary care hospital. One hundred and twenty A. baumannii clinical isolates were collected. Multiplex PCR was performed to detect genes encoding oxacillinases (OXA-23, OXA-24, OXA-51, OXA-58 and OXA-143). Molecular typing of all collected isolates was performed using random amplified polymorphic DNA (RAPD)-PCR assay. Out of 120 examined isolates, 92, 88 and 84% were resistant to ertapenem, imipenem and meropenem, respectively. The species-specific, commonly present OXA-51 gene was found in all isolates while OXA-23 showed a high prevalence of 88% of isolates. OXA-24 and OXA-143 genes were detected in 3% and 1% of isolates, respectively. No OXA-58 gene was detected. Five clusters consisting of 19 genotypes were detected using RAPD-PCR. Genotype A was the most prevalent, it was observed in 62% of the isolates followed by genotype B (12%). These results revealed that genotypes A and B are common in the hospital. Results also demonstrate that RAPD-PCR is a rapid and reliable method for studying the clonal similarity among A. baumannii isolated from different clinical specimens.

Keywords

References

  1. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21: 538-582. https://doi.org/10.1128/CMR.00058-07
  2. Kempf M, Rolain J. 2012. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe : Clinical impact and therapeutic options. Int. J. Antimicrob. Agents 39: 105-114. https://doi.org/10.1016/j.ijantimicag.2011.10.004
  3. Maragakis LL, Perl TM. 2008. Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46: 1254-1263. https://doi.org/10.1086/529198
  4. Shete VB, Ghadage DP, Muley VA, Bhore AV. 2010. Multi-drug resistant Acinetobacter ventilator-associated pneumonia. Lung India 27: 217-220. https://doi.org/10.4103/0970-2113.71952
  5. Manageiro V, Jones-Dias D, Ferreira E, Louro D. 2012. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118. Int. J. Antimicrob. Agents 40: 398-403. https://doi.org/10.1016/j.ijantimicag.2012.06.013
  6. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. 2007. Global challenge of multidrug-resistant Acinetobacter baumanni. Antimicrob. Agents Chemother. 51: 3471-3484. https://doi.org/10.1128/AAC.01464-06
  7. Lee H, Chen C, Wang S, Su L, Chen S, Liu S, et al. 2011. Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii : mechanism and clinical implications. Int. J. Antimicrob. Agents 37: 302-308. https://doi.org/10.1016/j.ijantimicag.2010.12.015
  8. Turton JF, Woodford N, Glover J, Yarde S. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44: 2974-2976. https://doi.org/10.1128/JCM.01021-06
  9. Lob SH, Hoban DJ, Sahm DF, Badal RE. 2016. Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii. Int. J. Antimicrob. Agents 47: 317-323. https://doi.org/10.1016/j.ijantimicag.2016.01.015
  10. Morfin-otero R, Dowzicky MJ. 2012. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the tigecycline evaluation and surveillance trial, 2004 to 2009. Clin. Ther. 34: 101-112. https://doi.org/10.1016/j.clinthera.2011.11.028
  11. Rynga D, Shariff M, Deb M. 2015. Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India. Ann. Clin. Microbiol. Antimicrob. 14: 40. https://doi.org/10.1186/s12941-015-0101-5
  12. Nasr RA, Attalah MF. 2012. Molecular epidemiology of nosocomial Acinetobacter baumannii isolates. Nat. Sci. 10: 76-82.
  13. Bart A, Schuurman IGA, Achtman M, Caugant DA, Dankert J, Ende A. 1998. Randomly amplified polymorphic DNA genotyping of serogroup a meningococci yields results similar to those obtained by multilocus enzyme electrophoresis and reveals new genotypes. J. Clin. Microbiol. 36: 1746-1749. https://doi.org/10.1128/JCM.36.6.1746-1749.1998
  14. Leal NC, Sobreira M, Leal-Balbino TC, Almeida AMP De, de Silva MJ, Mello DM, et al. 2004. Evaluation of a RAPD-based typing scheme in a molecular epidemiology study of Vibrio cholerae O1, Brazil. J. Appl. Microbiol. 96: 447-454. https://doi.org/10.1111/j.1365-2672.2004.02090.x
  15. Constantiniu S, Romaniuc A, Iancu LS, Filimon R. 2004. Cultural and biochemical characteristics of Acinetobacter spp. strains isolated from hospital units. J. Prev. Med. 12: 35-42.
  16. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27: 351-353. https://doi.org/10.1016/j.ijantimicag.2006.01.004
  17. Joshi PR, Acharya M, Kakshapati T, Leungtongkam U, Thummeepak R, Sitthisak S. 2017. Co-existence of blaOXA-23and blaNDM-1genes of Acinetobacter baumannii isolated from Nepal: Antimicrobial resistance and clinical significance. Antimicrob. Resist. Infect. Control 6: 21. https://doi.org/10.1186/s13756-017-0180-5
  18. Clinical Laboratory Standards Institute(CLSI). 2019. Performance standards for antimicrobial susceptibility testing. Clin. Lab Stand Inst. 29th ed., pp. 1-319.
  19. Manchanda V, Sinha S, Singh N. 2010. Multidrug resistant Acinetobacter. J. Glob Infect. Dis. 2: 291-304. https://doi.org/10.4103/0974-777X.68538
  20. Graser Y, Klare I, Halle E, Gantenberg R, Buchholz P, Jacobi HD, et al. 1993. Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting. J. Clin. Microbiol. 31: 2417-2420. https://doi.org/10.1128/jcm.31.9.2417-2420.1993
  21. Karthika RU, Rao RS, Sahoo S, Shashikala P, Kanungo R, Jayachandran S, et al. 2009. Phenotypic and genotypic assays for detecting the prevalence of metallo-b-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J. Med. Microbiol. 58: 430-435. https://doi.org/10.1099/jmm.0.002105-0
  22. Bassetti M, Righi E, Esposito S, Petrosillo N, Nicolini L. 2008. Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Future Microbiol. 3: 649-660. https://doi.org/10.2217/17460913.3.6.649
  23. Bonomo RA, Szabo D. 2006. Mechanisms of multidrug resistance in Acinetobacter Species and Pseudomonas aeruginosa. Clin. Infect. Dis. 43: S49-S56. https://doi.org/10.1086/504477
  24. Bonnin RA, Nordmann P, Poirel L. 2013. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: A state of the art. Expert Rev. Anti. Infect. Ther. 11: 571-583. https://doi.org/10.1586/eri.13.38
  25. Abdulzahra AT, Khalil MAF, Elkhatib WF. 2018. First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt. New Microbes New Infect. 26: 53-58. https://doi.org/10.1016/j.nmni.2018.08.007
  26. Sadeghifard N, Ranjbar R, Zaeimi J, Alikhanid MY, Ghafouryana S, Raftarie M, et al. 2010. Antimicrobial susceptibility, plasmid profiles, and RAPD-PCR typing of Acinetobacter bacteria. Asian Biomed. 4: 901-911. https://doi.org/10.2478/abm-2010-0118
  27. Shehta H, Abdalbagi S, Benmahmod B, Hassan R. 2018. Coproduction of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt. World J. Microbiol. Biotechnol. 34: 189. https://doi.org/10.1007/s11274-018-2571-z
  28. Azizi O, Shahcheraghi F, Salimizand H, Modaresi F. 2016. Molecular analysis and expression of bap gene in biofilm-forming multidrug-resistant Acinetobacter baumannii. reports. Biochem. Mol. Biol. 5: 62-72.
  29. Petrova AP, Stanimirova ID, Ivanov IN, Petrov MM, MitevaKatrandzhieva TM, Grivnev VI, et al. 2017. Carbapenemase production of clinical isolates Acinetobacter baumannii and Pseudomonas aeruginosa from a Bulgarian University Hospital. Folia Med. (Plovdiv) 59: 413-422. https://doi.org/10.1515/folmed-2017-0060
  30. Nwadike, Ugochukwu V, Kingsley C, Iche E. 2014. Multidrug resistant Acinetobacter infection and their antimicrobial susceptibility pattern in a Nigerian Tertiary Hospital ICU. J. Infect. Dis. 8: 14-18.
  31. Eftekhar F, Torkanpoory NE. 2018. Contribution of contaminated environmental surfaces to the transmission of multidrug-resistant Acinetobacter baumannii in special care units of a hospital in Tehran, Iran. J. Med. Microbiol. Infect. Dis. 6: 37-42.
  32. Lean S, Suhaili Z, Ismail S, Rahman NIA, Othman N, Abdullah FH, et al. 2014. Prevalence and genetic characterization of carbapenem- and polymyxin-resistant Acinetobacter baumannii isolated from a tertiary hospital in terengganu, Malaysia. ISRN Microbiol. 2014: 953417. https://doi.org/10.1155/2014/953417
  33. Fouad M, Attia AS, Tawakkol WM, Hashem AM. 2013. Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int. J. Infect. Dis. 17: e1252-e1254. https://doi.org/10.1016/j.ijid.2013.07.012
  34. Erturk A, Cicek AC, Gumu A, Cure E, Ahmet S, Kurt A, et al. 2014. Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units. Ann. Clin. Microbiol. Antimicrob. 13: 36. https://doi.org/10.1186/s12941-014-0036-2
  35. Pogue JM, Mann T, Barber KE, Kaye KS. 2013. Carbapenem-resistant Acinetobacter baumannii: Epidemiology, surveillance and management. Expert Rev. Anti. Infect. Ther. 11: 383-393. https://doi.org/10.1586/eri.13.14
  36. Evans BA, Amyes SGB. 2014. OXA beta-Lactamases. Clin. Microbiol. Rev. 27: 241-263. https://doi.org/10.1128/CMR.00117-13
  37. Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A. 2014. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int. J. Infect. Dis. 22: 49-54. https://doi.org/10.1016/j.ijid.2013.12.004
  38. Hamouda A, Evans BA, Towner KJ, Amyes SGB. 2010. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla OXA-51-like genes. J. Clin. Microbiol. 48: 2476-2483. https://doi.org/10.1128/JCM.02431-09
  39. Touati M, Diene SM, Racherache A, Dekhil M, Djahoudi A, Rolain JM. 2012. Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int. J. Antimicrob. Agents 40: 84-93. https://doi.org/10.1016/j.ijantimicag.2012.03.011
  40. Abbott I, Cerqueira GM, Bhuiyan S, Peleg AY. 2013. Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev. Anti. Infect. Ther. 11: 395-409. https://doi.org/10.1586/eri.13.21
  41. Merino Ma, Poza M, Roca I. 2014. Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain. Microb. Drug Resist. 20: 259-263. https://doi.org/10.1089/mdr.2013.0127
  42. Dettori M, Piana A, Deriu MG, Lo Curto P, Cossu A, Musumeci R, et al. 2014. Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit. New Microbiol. 37: 185-191.
  43. Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, et al. 2010. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system : impact of postacute care facilities on dissemination. J. Antimicrob. Chemother. 65: 1807-1818. https://doi.org/10.1093/jac/dkq191
  44. Farshadzadeh Z, Hashemi FB, Rahimi S, Pourakbari B. 2015. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front. Microbiol. 6: 1146. https://doi.org/10.3389/fmicb.2015.01146
  45. Vali L, Dashti K, Opazo-capurro AF, Dashti AA, Al Obaid K, Evans BA. 2015. Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait. Front. Immunol. 6: 743.
  46. Lopes BS, Al-agamy MH, Ismail MA, Shibl AM, Al-Qahtani AA, AlAhdal MN, et al. 2015. The transferability of blaOXA-23 gene in multidrug-resistant Acinetobacter baumannii isolates from Saudi Arabia and Egypt. Int. J. Med. Microbiol. 305: 581-588. https://doi.org/10.1016/j.ijmm.2015.07.007
  47. Zowawi HM, Sartor AL, Sidjabat HE, Balkhy HH, Walsh TR, Al Johani SM, et al. 2015. Molecular epidemiology of carbapenemresistant Acinetobacter baumannii isolates in the gulf cooperation council states : Dominance of OXA-23-Type producers. J. Clin. Microbiol. 53: 896-903. https://doi.org/10.1128/JCM.02784-14
  48. Ranjbar R, Zayeri S, Afshar D, Farshad S. 2019. Detection of OXA beta lactamases among clinical isolates of Acinetobacter baumannii isolated from Tehran hospitals, Iran. Open Microbiol. J. 13: 68-72. https://doi.org/10.2174/1874285801913010068
  49. Handal R, Qunibi L, Sahouri I, Juhari M, Dawodi R, Marzouqa H, et al. 2017. Characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from hospitalized patients in palestine. Int. J. Microbiol. 2017: 8012104.
  50. Chang Y, Luan G, Xu Y, Wang Y. 2015. Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital. Front. Microbiol. 6: 690.
  51. Bannah AMS El, Nawar NN, Hassan RMM, Salem STB. 2017. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Egypt : clonal spread of bla OXA-23. Microb. Drug Resist. 24: 269-277. https://doi.org/10.1089/mdr.2017.0057
  52. Al Atrouni A, Hamze M, Jisr T, Limarie C, Eveillard M, Joly-Guillou M, et al. 2016. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon. Int. J. Infect. Dis. 52: 29-36. https://doi.org/10.1016/j.ijid.2016.09.017
  53. Pujol C, Joly S, Lockhart SR, Noel S, Tibayrenc M, Soll DR. 1997. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme dlectrophoresis, and southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J. Clin. Microbiol. 35: 2348-2358. https://doi.org/10.1128/jcm.35.9.2348-2358.1997
  54. Li X, Xie Y, Wang M, Xia X, Wang M, Cao W, et al. 2016. Phenotypic and genomic diversity in Acinetobacter baumannii stains random isolated from 2008 to 2012 in a teaching hospital in Hunan, China. Int. J. Clin. Exp. Pathol. 9: 7030-7039.
  55. Kanj SS, Tayyar R, Shehab M, El-Hafi B, Rasheed SS, Kissoyan KAB, et al. 2018. Increased bla OXA-23-like prevalence in Acinetobacter baumannii at a tertiary care center in Lebanon (2007-2013). J. Infect. Dev. Ctries 12: 228-234. https://doi.org/10.3855/jidc.9642
  56. Novovic K, Mihajlovic S, Vasiljevic Z, Filipic B. 2015. Carbapenemresistant Acinetobacter baumannii from Serbia : Revision of CarO classification. PLoS One 10: e0122793. https://doi.org/10.1371/journal.pone.0122793
  57. Koeleman JGM, Stoof J, Biesmans DJ, Savelkoul PH, Vandenbroucke-Grauls CM. 1998. DNA Analysis, and amplified fragment length polymorphism fingerprinting for identification of acinetobacter gnomic species and typing of Acinetobacter baumannii. J. Clin. Microbiol. 36: 2522-2529. https://doi.org/10.1128/JCM.36.9.2522-2529.1998